vs

Side-by-side financial comparison of Capitol Federal Financial, Inc. (CFFN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $57.7M, roughly 1.4× Capitol Federal Financial, Inc.). Capitol Federal Financial, Inc. runs the higher net margin — 34.9% vs -38.1%, a 73.0% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 12.1%).

Capitol Federal Savings Bank (CapFed) is a federally chartered and insured savings bank founded in 1893 and headquartered in Topeka, Kansas. Capitol Federal has 51 locations serving both the Kansas and Missouri sides of the Kansas City metropolitan area with personal and business financial services. It is owned by holding company Capitol Federal Financial Inc. for trading on the Nasdaq.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CFFN vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$57.7M
CFFN
Higher net margin
CFFN
CFFN
73.0% more per $
CFFN
34.9%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
12.1%
CFFN

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
CFFN
CFFN
PRCT
PRCT
Revenue
$57.7M
$83.1M
Net Profit
$20.1M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
34.9%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CFFN
CFFN
PRCT
PRCT
Q1 26
$57.7M
$83.1M
Q4 25
$56.8M
$76.4M
Q3 25
$54.6M
$83.3M
Q2 25
$50.7M
$79.2M
Q1 25
$48.8M
$69.2M
Q4 24
$46.9M
$68.2M
Q3 24
$58.4M
Q2 24
$45.0M
$53.4M
Net Profit
CFFN
CFFN
PRCT
PRCT
Q1 26
$20.1M
$-31.6M
Q4 25
$20.3M
$-29.8M
Q3 25
$18.8M
$-21.4M
Q2 25
$18.4M
$-19.6M
Q1 25
$15.4M
$-24.7M
Q4 24
$15.4M
$-18.9M
Q3 24
$-21.0M
Q2 24
$9.6M
$-25.6M
Gross Margin
CFFN
CFFN
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
CFFN
CFFN
PRCT
PRCT
Q1 26
-4.1%
Q4 25
44.4%
-40.6%
Q3 25
42.2%
-27.8%
Q2 25
42.6%
-28.0%
Q1 25
39.5%
-39.7%
Q4 24
40.7%
-28.9%
Q3 24
-38.4%
Q2 24
34.7%
-50.3%
Net Margin
CFFN
CFFN
PRCT
PRCT
Q1 26
34.9%
-38.1%
Q4 25
35.7%
-39.1%
Q3 25
34.5%
-25.7%
Q2 25
36.2%
-24.7%
Q1 25
31.6%
-35.8%
Q4 24
32.9%
-27.6%
Q3 24
-35.9%
Q2 24
21.4%
-48.0%
EPS (diluted)
CFFN
CFFN
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.16
$-0.54
Q3 25
$0.14
$-0.38
Q2 25
$0.14
$-0.35
Q1 25
$0.12
$-0.45
Q4 24
$0.12
$-0.34
Q3 24
$-0.40
Q2 24
$0.07
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CFFN
CFFN
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$2.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$1.0B
$347.7M
Total Assets
$9.8B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CFFN
CFFN
PRCT
PRCT
Q1 26
$2.5M
$245.6M
Q4 25
$232.6M
$286.5M
Q3 25
$252.4M
$294.3M
Q2 25
$175.0M
$302.7M
Q1 25
$340.4M
$316.2M
Q4 24
$170.3M
$333.7M
Q3 24
$196.8M
Q2 24
$317.8M
$214.1M
Total Debt
CFFN
CFFN
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CFFN
CFFN
PRCT
PRCT
Q1 26
$1.0B
$347.7M
Q4 25
$1.0B
$365.9M
Q3 25
$1.0B
$380.3M
Q2 25
$1.0B
$385.8M
Q1 25
$1.0B
$389.2M
Q4 24
$1.0B
$402.2M
Q3 24
$241.2M
Q2 24
$1.0B
$251.8M
Total Assets
CFFN
CFFN
PRCT
PRCT
Q1 26
$9.8B
$487.1M
Q4 25
$9.8B
$508.1M
Q3 25
$9.8B
$511.5M
Q2 25
$9.7B
$513.1M
Q1 25
$9.7B
$519.4M
Q4 24
$9.5B
$534.0M
Q3 24
$374.1M
Q2 24
$9.6B
$374.4M
Debt / Equity
CFFN
CFFN
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CFFN
CFFN

Net Interest Income$52.3M91%
Noninterest Income$5.5M9%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons